2015 Speaker List 


  • Abhijit A. Patel, M.D., Ph.D., Assistant Professor, Department of Therapeutic Radiology, Yale University School of Medicine
  • Adithya Cattamanchi, M.D., Assistant Professor, University of California, San Francisco School of Medicine
  • Ahmed Enayetallah, M.D., Ph.D., Senior Scientist, Value Based Medicine, Biogen Idec
  • Ajay Shah, Ph.D., MBA, PMP, Director, Research Informatics & Systems, City of Hope National Medical Center
  • Alan B. Carter, President, MDx Consultin
  • Alan L. Epstein, M.D., Ph.D., Department of Pathology, USC Keck School of Medicine, Los Angeles
  • Alan Wahl, Ph.D., Vice President, Research and Discovery, Ambrx, Inc.
  • Albert A. Luderer, Ph.D., Chief Executive Officer, Integrated Diagnostics (IndiDx.)
  • Alex J. Adams, Pharm.D., IOM, Vice President, Pharmacy Programs, National Association of Chain Drug Stores (NACDS)
  • Alexander Kamb, Ph.D., Senior Vice President, Discovery Research, Amgen
  • Alexandra Glucksmann., Ph.D., COO, Editas Medicine
  • Alexis B. Carter, M.D., Assistant Professor, Pathology and Laboratory Medicine; Member, Center for Comprehensive Informatics; Director, Pathology Informatics, Emory University School of Medicine;
  • Alison Devonshire, Ph.D., Science Leader, Nucleic Acid Metrology, LGC Genomics
  • Allan B. Dietz, Ph.D., Co-Director, The Human Cell Therapy Lab, Mayo Clinic Center for Regenerative Medicine
  • Allan T. Bombard, M.D., MBA, Chief Medical Officer, Progenity, Inc.
  • Allison Dering-Anderson, Pharm.D., RP, FAAIM, Clinical Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy
  • Allison Welsh, Ph.D., CTC Scientist, Foundation Medicine, Inc. Benjamin Casavant, Ph.D., Vice President, Tasso
  • AmirAli Talasaz, Ph.D., President & CTO, Guardant Health, Inc.
  • Andreas Friese, Head, Research-IT, Bayer HealthCare R&D-IT, Bayer HealthCare AG
  • Andreas Scherer, Ph.D., President and CEO, Golden Helix
  • Andrew Brooks, Ph.D., COO, RUCDR Infinite Biologics, Rutgers University
  • Andrew Goldsborough, Ph.D., CEO, RNA Stability, RNAssist Ltd
  • Andrew Quinn, M.D., Fellow, Cytology, Pathology, Brigham and Women’s Hospital
  • Andrew Stubbs, Ph.D., Assistant Professor, Bioinformatics, Erasmus University Medical Center
  • Andrew Webb, CEO, EKF Molecular Diagnostics
  • Angel Pizarro, Senior Solutions Architect, Amazon Web Services
  • Anil Srivastava, President, Open Health Systems Laboratory
  • Arijit Chakravarty, Ph.D., Director, Modeling & Simulation (DMPK), Takeda Pharmaceutical International Co.
  • Arturo J. Morales, Ph.D., Vice President, Informatics, Beryllium Corp.
  • Arun Ganguly, Managing Director, The Ganguly Grou
  • Atul Butte, M.D., Ph.D., Division Chief and Associate Professor, Stanford University School of Medicine; Director, Center for Pediatric Bioinformatics, Lucile Packard Children’s Hospital; Co-Founder, Personalis and NuMedi.
  • Austin Tanney, Ph.D., Marketing Manager, Almac Discovery and Diagnostics, Almac
  • Avraham Rasooly, Ph.D., Health Scientist Administrator, Division of Cancer Treatment and Diagnosis, National Cancer Institute
  • B. Jayaram, Ph.D., Professor, Department of Chemistry & Professor, Kusuma School of Biological Sciences, and Coordinator, Supercomputing Facility for Bioinformatics & Computational Biology, Indian Institute of Technology Delhi
  • Barbara Mittleman, M.D., Vice President, Clinical; Head, Immunology, Nodality
  • Barry Bunin, Ph.D., CEO, Collaborative Drug Discovery (CDD), Inc.
  • Barry Lutz, Ph.D., Research Assistant Professor, Department of Bioengineering, University of Washington
  • Ben Busby, Ph.D., Genomics Outreach Coordinator, NCBI, NIH
  • Benjamin P. Berman, Ph.D., Assistant Professor, Bioinformatics, Preventive Medicine; Member, USC Epigenome Center, University of Southern California
  • Benjamin Tycko, M.D., Ph.D., Professor, Pathology and Cell Biology, Institute for Cancer Genetics & Taub Institute for Research on Alzheimer’s Disease and the Aging Brain, Columbia University
  • Bernard A. Fox, Ph.D., Endowed Chair and Chief, Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center; Earle A Chiles Research Institute, Providence Cancer Center; Dept Molecular Microbiology and Immunology, OHSU
  • Beverly E. Faulkner-Jones, M.D., Ph.D., Staff Pathologist, Pathology, Beth Israel Deaconess Medical Center
  • Birgitt Schuele, M.D., Associate Professor and Director of Gene Discovery and Stem Cell Modeling, The Parkinson’s Institute
  • Brian Haynes, Ph.D., Senior Scientist, Asuragen
  • Brian J. Kirby, Ph.D., Associate Professor, Mechanical and Aerospace Engineering, Cornell University
  • Brian Strahl, Ph.D., Associate Professor & Director, Graduate Studies of Biochemistry & Biophysics, University of North Carolina School of Medicine
  • Bruce R. Conklin M.D., Investigator, Roddenberry Center for Stem Cell Biology and Medicine, Gladstone Institutes and Professor, Division of Genomic Medicine University of California, San Francisco
  • Bruce R. Korf, M.D., Ph.D., Wayne H. and Sara Crews Finley Chair in Medical Genetics; Professor and Chair,Genetics; Director, Heflin Center for Genomic Sciences, University of Alabama at Birmingham
  • Carl T. Wittwer, M.D., Ph.D., Professor, Pathology, University of Utah
  • Caroline Dive, B.Pharm, Ph.D., Professor & Senior Group Leader, Clinical and Experimental Pharmacology Group, Cancer Research UK Manchester Institute
  • Carolyn Compton, M.D., Ph.D., Professor, School of Life Sciences, Arizona State University
  • Catherine Schnabel, Ph.D., Senior Vice President, Research & Development, bioTheranostics, Inc.
  • Chair, AMP Informatics Interest Group; President, Association of Pathology Informatics
  • Charles A. Gersbach, Ph.D., Assistant Professor, Department of Biomedical Engineering, Center for Genomic and Computational Biology, Duke University
  • Charles Chiu, M.D., Ph.D., Assistant Professor, Laboratory Medicine and Medicine/Infectious Diseases; Director, UCSF-Abbott Viral Diagnostics and Discovery Center; Associate Director, UCSF Clinical Microbiology Laboratory, UCSF School of Medicin
  • Charles Cox, Ph.D., Head, Genetics Experiment Design and Delivery, GlaxoSmithKline
  • Charles Glaus, Ph.D., Senior Scientist, Research Imaging Sciences, Amgen
  • Charles Stemple, DO, MBS, Corporate Medical Director, Commercial Clinical Policy, Human.
  • Chelsea Loughran, Associate, Litigation Group, Wolf, Greenfield and Sacks, P.C.
  • Chetan Bettegowda, M.D., Ph.D., Assistant Professor, Neurosurgery & Oncology, Johns Hopkins University School of Medicine
  • Chris Karlovich, Ph.D., Principal Scientist, Molecular Diagnostics, Clovis Oncology
  • Christa Lese Martin, Ph.D., FACMG, Director & Senior Investigator, Autism & Developmental Medicine Institute (ADMI), Geisinger Health System
  • Christine Hara, Consultant
  • Christopher E. Mason, Ph.D., Assistant Professor, Computational Biomedicine, Weill Cornell Medical College
  • Chrystal Adams, Associate Vice President, Marketing, XIFIN
  • Cigall Kadoch, Ph.D., Assistant Professor, Pediatric Oncology, Dana-Farber Cancer Institute and Harvard Medical School
  • Cloud P. Paweletz, Ph.D., Head, Translational Research Laboratory; Biomarker Lead, Belfer Institute for Applied Cancer Science, Dana Farber Cancer Institute
  • Cole Trapnell, Ph.D., Assistant Professor, Genome Sciences, University of Washington
  • Corporate Development, Myriad RBM
  • Corrado Priami, Ph.D., Computer Science, The Microsoft Research - University of Trento Centre for Computational and Systems Biology (COSBI)
  • Dalia Cohen, Ph.D., Head, Research, Beryllium
  • Dan Roden, M.D., William Stokes Professor, Experimental Therapeutics; Professor, Medicine and Pharmacology; Assistant Vice Chancellor, Personalized Medicine, Vanderbilt University
  • Dane J. Dickson, M.D., Director, Clinical Science, MolDx, Palmetto GBa
  • Daniel Appella, Ph.D., Senior Investigator, LBC, NIDDK, NIH
  • Daniel C. Danila, M.D., Assistant Attending, Medicine, Memorial Sloan Kettering Cancer Center
  • Daniel F. Hayes, M.D., FASCO, Stuart B. Padnos Professor, Breast Cancer Research; Clinical Director, Breast Oncology Program, Internal Medicine and Hematology Oncology, University of Michigan Comprehensive Cancer Center
  • Daniel G. Anderson, Ph.D., Professor, Department of Chemical Engineering, Institute for Medical Engineering & Science, Harvard-MIT Division of Health Sciences & Technology and David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
  • Daniel H. Farkas, Ph.D., HCLD, FACB, Laboratory Director, Sequenom Center for Molecular Medicine
  • Daniel S. Grosu, M.D., M.B.A. Vice President, Clinical Development & Medical Affairs, Illumina, Inc.
  • Daniel T. Chiu, Ph.D., A. Bruce Montgomery Professor, Chemistry & Bioengineering, University of Washington, Seattle
  • Daniela Starcevic, Ph.D., Director, Diagnostic Sequencing; Assistant Professor, Genomics and Multiscale Biology; Assistant Professor, Pathology; Icahn School of Medicine at Mount Sinai
  • David A. Weitz, Ph.D., Mallinckrodt Professor, Physics, School of Engineering & Applied Sciences, Harvard University
  • David Anstey, MBA, Global Head, Life Sciences, Cray, Inc.
  • David Colter, Ph.D., Principal Scientist, Biologics Research, Janssen
  • David Gandara, M.D., Professor of Medicine, Division of Hematology/Oncology, University of California, Davis School of Medicine; Director, Thoracic Oncology Program, Senior Advisor to the Director, UC Davis Comprehensive Cancer Center; Chair, Lung Committee, Southwest Oncology Group (SWOG)
  • David Godler, Ph.D., Senior Research Fellow, Cyto-molecular Diagnostics Research and Victorian Clinical Genetics Services; Head, The FMR1 Related Disorders Group, Murdoch Children’s Research Institute, Royal Children’s Hospital
  • David Haussler, Ph.D., Distinguished Professor and Director, Center for Biomolecular Science & Engineering, University of California Santa Cruz
  • David Hoon, Ph.D., Chief, Scientific Intelligence, Director, Molecular Oncology, John Wayne Cancer Institute
  • David Jackson, Ph.D, CSO, MolecularHealth, Inc
  • David L. Rimm, M.D., Ph.D., Professor, Pathology; Executive Director, Translational Pathology; Director, Yale Pathology Tissue Services, Yale University
  • David R. Hillyard, M.D., Medical Director, Molecular Infectious Diseases, Arup Laboratories
  • David Shames, Ph.D., Senior Scientist, Genentech
  • Debraj GuhaThakurta, Director, Computational & Systems Biology, Dendreon Corporation
  • Devon Kelly, Director, OHSU Knight BioLibrary, Knight Cancer Institute, Oregon Health and Science University
  • Dietrich A. Stephan, Ph.D., Professor & Chairman, Human Genetics, University of Pittsburgh; Associate Director, Population Genetics and Translational Acceleration, Institute for Personalized Medicine of UPMC & University of Pittsburgh Health
  • Dino Di Carlo, Ph.D., Associate Professor, Bioengineering, California NanoSystems Institute, Jonsson Comprehensive Cancer Center, University of California, Los Angeles
  • Dirk G. Brockstedt, Ph.D., Senior Vice President, Research & Development, Aduro BioTech, Inc.
  • Donald G. Munroe, Ph.D., Senior Vice President, Business Development; Chief Scientific Officer, R&D, Vermillion, Inc.
  • Donald Jeffrey Zack, M.D., Ph.D., Guerrieri Professor, Genetic Engineering & Molecular Ophthalmology; Professor, Molecular Biology & Genetics, Neuroscience, and the Institute of Genetic Medicine, John’s Hopkins School of Medicine
  • Donald Klepser, Ph.D., MBA, Assistant Professor, Pharmacy Practice, University of Nebraska Medical Center College of Pharmacy
  • Dongliang Ge, Ph.D., Director, Bioinformatics, Gilead Sciences
  • Doug Storts, Ph.D., Head, Nucleic Acid Technologies, Promega Corporation
  • Douglas Horejsh, Ph.D., Senior Research Scientist, Promega Corporation
  • Douglas J. Hartman, M.D., Assistant Professor, Pathology, University of Pittsburgh Medical Center
  • Edgar Braendle, M.D., Ph.D., Senior Vice President & Global Head, Companion Diagnostics, Novarti
  • Edward Abrahams, Ph.D., President, Personalized Medicine Coalition
  • Edward Wolf, M.D., President, New Jersey Perinatal Associate
  • Elaine Lyon, Ph.D., Medical Director, Molecular Genetics, ARUP (AMP 2014 President and Member, AMP Professional Relations Committee
  • Elizabeth A. Wagar, M.D., Professor and Chair, Laboratory Medicine, MD Anderson Cancer Center
  • Elizabeth Punnoose, Ph.D., Senior Scientist, Oncology Biomarker Development, Genentech, Inc.
  • Elizabeth Worthey, Ph.D., Assistant Professor, Pediatrics & Bioinformatics Program, Human & Molecular Genetics Center, Medical College of Wisconsin
  • Elli Kaplan, CEO, Neurotrack
  • Emad Elsebakhi, Ph.D., Principal Investigator, Division of Biomedical Informatics, Sidra Medical and Research Center
  • Enrico Picozza, MS, Venture Partner, HLM Venture Partner.
  • Eric C. Holland, M.D., Ph.D., Senior Vice President, Director,Human Biology, Solid Tumor Translational Research, Nancy and Buster Alvord Brain Tumor Center, Fred Hutchinson Cancer Research Center, University of Washington
  • Eric F. Glassy, M.D., Medical Director, Pathology, Inc.
  • Eric N. Olson, Ph.D., Professor and Chairman, Department of Molecular Biology, The University of Texas Southwestern Medical Center
  • Erik Bierwagen, Principal Programmer Analyst, Genentech Sergio Rotstein, Ph.D., Director, Research Business Technology, Pfizer, Inc.
  • Euan Ashley, D.Phil., Associate Professor, Medicine and Genetics; Director, Stanford Center for Inherited Cardiovascular Disease, Stanford University School of Medicine
  • Farideh Z. Bischoff, Ph.D., Executive Director, Scientific Affairs, Silicon Biosystems
  • Federico A. Monzon, M.D., FCAP, Director, Oncology, InVitae; Adjunct Faculty, Baylor College of Medicine
  • Fei Ann Ran, Ph.D., Post-Doctoral Fellow, Laboratory of Dr. Feng Zhang, Broad Institute and Junior Fellow, Harvard Society of Fellows
  • Felipe de Sousa e Melo, Postdoctoral Research Fellow, Molecular Oncology, Genentech
  • Francisco M. De La Vega, D.Sc., Visiting Instructor, Department of Genetics, Stanford University School of Medicine
  • François Forester, Ph.D., Professor, Haematology, University Paris 11, ScreenCell
  • Frank Loganzo, Ph.D., Director, ADC Biochemistry, Oncology, Pfizer
  • Frank S. Ong, M.D., Associate Director, Medical Affairs, Illumina, Inc.
  • Frederic de Sauvage, Ph.D., Vice President, Molecular Oncology, Genentech
  • Frieda Gerdes, Managing Director, Management, Gerdes Healthcare Communication UG
  • G. Mike Makrigiorgos, Ph.D., Professor, Radiation Oncology, Dana Farber and Harvard Medical School
  • Gabe Rudy, Vice President, Product Development, Golden Helix
  • Gabe Rudy, Vice President, Product Development, Golden Helix
  • Gabriele Bergers, Ph.D., Professor of Neurological Surgery, Neill H. and Linda S. Brownstein Endowed Chair in Brain Tumor Research, Principal Investigator, Brain Tumor Research Center, University of California, San Francisco
  • Gang Bao, Ph.D., Robert A. Milton Chair Professor in Biomedical Engineering, Department of Biomedical Engineering, Georgia Institute of Technology and Emory University
  • George Calin, M.D., Ph.D., Professor, Experimental Therapeutics and Leukemia, MD Anderson Cancer Center
  • German Pihan, M.D., Director, Hematopathology Lab, Pathology, Beth Israel Deaconess Medical Center & Harvard Medical School
  • Glenn A. Miller, Ph.D., CTO & Executive Vice President, MolecularMD
  • Grant Campany, Senior Director, XPRIZE
  • Gregory Cooper, Ph.D., Faculty Investigator, HudsonAlpha Institute for Biotechnology
  • Gregory Y. Lauwers, M.D., Professor & Vice Chair, Pathology, Massachusetts General Hospital
  • Guido Hennig, Ph.D., Senior Global Scientific Affairs Manager, BU Molecular Global Marketing, Siemens Healthcare Diagnostics
  • H. Kim Lyerly, M.D., George Barth Geller Professor of Cancer Research, Duke University; Director, Duke Comprehensive Cancer Center
  • Hadley D. Sikes, Ph.D., Joseph R. Mares Assistant Professor, Chemical Engineering, Massachusetts Institute of Technology
  • Hakan Sakul, Ph.D., Executive Director and Head, Diagnostics, Worldwide R&D, Development Operations, Pfizer, Inc.
  • Hakon Hakonarson, M.D., Ph.D., Director, Center for Applied Genomics, Children’s Hospital of Philadelphia
  • Han Liang, Ph.D., Assistant Professor, Department of Bioinformatics and Computational Biology, Division of Quantitative Sciences, The University of Texas, MD Anderson Cancer Center
  • Hanlee Ji, M.D., Assistant Professor,Oncology, Medicine, Stanford University School of Medicine; Senior Associate Director, Stanford Genome Technology Center
  • Hans-Peter Gerber, Ph.D., Vice President, BioConjugates Discovery & Development, Oncology Research Unit East, Pfizer Worldwide Research and Development
  • Hanyoup Kim, Ph.D., Senior Scientist, Canon U.S. Life Sciences, Inc.
  • Harry Glorikian, Healthcare Consultant Elaine Cheung, Business & Corporate Development, Illumina
  • Héctor Corrada Bravo, Ph.D., Assistant Professor, Computer Science, UM Institute for Advanced Computer Studies & Center for Bioinformatics and Computational Biology, University of Maryland
  • Helen Moore, Ph.D., Branch Chief, Biorepositories & Biospecimen Research Branch, Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute
  • Hemanth Shenoi, Ph.D., Director, Business Development, Lucigen Corporation
  • Holden T. Maecker, Ph.D., Associate Professor (Research), Microbiology & Immunology, Stanford University
  • Hong Cai, Ph.D., CEO, Mesa Tech International, Inc.
  • Ian Foster, Ph.D., Director, Computation Institute, Argonne National Lab
  • Ido Amit, Ph.D., Associate Professor, Immunology; Principal Investigator, Laboratory for Immuno-Genomics, Weizmann Institute of Science
  • Inder Singh, CEO, Kinsa, Inc.
  • Ira Mellman, M.D., Vice President, Cancer Immunology, Genentech
  • Iris Schrijver, M.D., Professor of Pathology and Pediatrics; Director, Molecular Pathology Laboratory, Stanford University Medical Center, Lucile Packard Children’s Hospital
  • Ite A. Laird-Offringa, Ph.D., Associate Professor,Surgery and of Biochemistry and Molecular Biology, Norris Cancer Center, Keck School of Medicine, University of Southern California
  • Ivet Bahar, PhD, Distinguished Professor and John K Vries Chair, Department of Computational & Systems Biology, School of Medicine, University of Pittsburgh
  • J. Carl Barrett, Ph.D., Vice President, Translational Sciences, Onc iMed, AstraZeneca
  • Jae Lee, Ph.D., Chair and Senior Member, Biostatistics and Bioinformatics, Moffitt Cancer Center
  • Jake Klamka, Founder, Insight Data Science Fellows Program
  • James Evans, M.D., Ph.D., Bryson Distinguished Professor, Genetics and Medicine,Genetics, University of North Carolina School of Medicine
  • James F. Smothers, Ph.D., Senior Director& Head, Discovery, Immuno-Oncology & Combinations DPU, Oncology R&D, GlaxoSmithKline
  • James Keck, Senior Director, Clinical Lab & In Vivo Pharmacology Services, The Jackson Laboratory
  • James Lyons-Weiler, Ph.D., Scientific Director, Bioinformatics Analysis Core Genomics and Proteomics Core Laboratory, University of Pittsburgh
  • James M. Ford, M.D., Associate Professor, Medicine & Genetics, Division of Oncology, Stanford University School of Medicine
  • James R. Mansfield, Director, Quantitative Pathology Applications, PerkinElmer
  • James Taylor, Ph.D., Ralph S. O’Connor Associate Professor, Biology; Associate Professor, Computer Science, Johns Hopkins University
  • Jamie L Platt, Ph.D., Vice President, Genomic Solutions, Molecular Pathology Laboratory Network, Inc.
  • Janis Taube, M.D., MSc, Director, Dermatopathology; Assistant Professor, Dermatology and Pathology, Johns Hopkins
  • Jason Baum, Ph.D., Associate Director, Companion Diagnostics, Research, Merrimack Pharmaceuticals
  • Jason Lih, Ph.D., Principal Scientist, Molecular Characterization Group, Leidos Biomedical Research, Inc./Frederick National Laboratory for Cancer Research
  • Javed Khan, M.D., Genetics BranchHead, Oncogenomics SectionDeputy Branch Chief, Center for Cancer Research, National Cancer Institute
  • Jaya Goyal, Ph.D., Director, Value Based Medicine, Biogen Idec
  • Jean Yuan, Senior Programming Analyst, Genentech Doug Garrett, Software Engineer, Genentech
  • Jeff Boyd, Ph.D., Senior Vice President, Molecular Medicine; The Robert C. Young Chair in Cancer Research; Executive Director, Cancer Genome Institute; Chief, Division of Molecular Pathology; Professor, Cancer Biology Program, Fox Chase Cancer Center
  • Jeffrey A. Dubois, Ph.D., Vice President, Medical & Scientific Affairs, Nova Biomedical
  • Jeffrey Fine, M.D., Assistant Professor, Pathology, University of Pittsburgh School of Medicine
  • Jeffrey Reid, Ph.D., Director & Head, Genome Informatics, Regeneron Pharmaceuticals
  • Jen Jen Yeh, M.D., Associate Professor, Surgery and Pharmacology, UNC Chapel Hill Lineberger Comprehensive Cancer Center
  • Jennifer Brogdon, Ph.D., Senior Investigator, Oncology Cell and Immunotherapies, Novartis Institutes for BioMedical Research, Inc.
  • Jennifer Doudna, Ph.D., Professor, Molecular and Cell Biology, Chemistry,University of California, Berkeley; Investigator & Professor, Biochemistry, Biophysics & Structural Biology, Howard Hughes Medical Institute
  • Jennifer J.D. Morrissette, Ph.D., FACMG, Scientific Director, Clinical Cancer Cytogenetics; Clinical Director, Center for Personalized Diagnostics; Pathology, University of Pennsylvani
  • Jens Lohr, M.D., Ph.D., Instructor in Medicine, Medical Oncology, Cancer Program, Dana-Farber Cancer Institute; Broad Institute
  • Jerry Conway, Vice President, Reimbursement & Payer Strategy, Foundation Medicine, Inc.
  • Jessica Owens, Acumen
  • Jian Han, Ph.D., Faculty Investigator, iCubate, HudsonAlpha Institute for Biotechnology
  • Jianping Fu, Ph.D., Mechanical Engineering & Biomedical Engineering, University of Michigan, Ann Arbo
  • Jin Billy Li, Ph.D., Assistant Professor, Genetics, Stanford University
  • Jo-Anne Vergilio, M.D., Associate Medical Director, Foundation Medicine, Inc.
  • Joel Dudley, Ph.D., Director, Biomedical Informatics; Assistant Professor, Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai
  • John A. Martignetti, M.D., Ph.D., Genetics and Genomic Sciences, Pediatrics, Obstetrics/Gynecology & Reproductive Sciences and Oncological Sciences, Icahn School of Medicine at Mount Sinai
  • John Pfeifer, M.D., Ph.D., Vice Chair for Clinical Affairs, Pathology; Professor, Pathology and Immunology; Professor, Obstetrics and Gynecology, Washington University School of Medicine
  • John W. Hanna, Senior Director, Policy & Reimbursement, Veracyt
  • Jonas S. Almeida, Ph.D., Professor and Division Director, Pathology, University of Alabama Birmingham
  • Jonathan Allen, Ph.D., Bioinformatics Scientist, Global Security Computing Applications, Lawrence Livermore National Laboratory
  • Jonathan Drachman, M.D., CMO & Executive Vice President, Research and Development, Seattle Genetics
  • Jonathan O’Halloran, CSO and Co-Founder, Board, QuantuMDx Group
  • Jonathan Pan, Ph.D, MBA, Director, Oncology Companion Diagnostic and Disease Strategy, GlaxoSmithKline
  • Jonathan Scolnick, Ph.D., Scientist, Research, NuGEN Technologies
  • Jorge S. Reis-Filho, M.D., Ph.D., FRCPath, Attending Pathologist, Pathology, Memorial Sloan-Kettering Cancer Center
  • Joseph C. Wu, M.D., Ph.D., Director, Stanford Cardiovascular Institute and Professor, Department of Medicine/Cardiology & Radiology, Stanford University School of Medicine
  • Joseph Costello, Ph.D., Professor in Residence, Neurological Surgery; Director, Epigenetics Division, Cell Cycling and Signaling Program, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco
  • Josh Deignan, Ph.D., Associate Director, UCLA Molecular Diagnostics Laboratories, Department of Pathology and Laboratory Medicine, David Geffen School of Medicine, UCLA
  • Joshua M. Lang, M.D., MS, Assistant Professor of Medicine, Carbone Cancer Center, University of Wisconsin, Wisconsin Institutes for Medical Research
  • Juan Carlos Izpisua Belmonte, Ph.D., Roger Guillemin Chair Professor, Gene Expression Laboratory, The Salk Institute for Biological Studies
  • Juan-Sebastian Saldivar, M.D., FACMG, Vice President, Clinical Services and Medical Affairs, Sequenom Laboratoris
  • Juergen Hammer, Ph.D., MBA, Roche Pharmaceutical Research and Early Development; Center Head, Informatics/IT; Global Head, Data Science, Roche Innovation Center New York
  • Kai Wang, Ph.D., Principal Scientist, Institute for Systems Biology
  • Kamlesh Patel, Ph.D., Manager, Advance Systems Engineering and Deployment, Sandia National Labs
  • Karl V. Voelkerding, M.D., Professor, Pathology, University of Utah; Medical Director, Genomics and Bioinformatics, ARUP Laboratories
  • Karl Voelkerding, M.D., Associate Professor, Pathology, University of Utah; Medical Director, Advanced Technology and Bioinformatics, ARUP Laboratories
  • Keith Batchelder, M.D., Founder & CEO, Genomic Healthcare Strategies
  • Kelly McVearry, Ph.D., Chief Scientist, Ekagra Technologies in collaboration with FDA
  • Ken Chang, Ph.D., Senior Principal Scientist, Molecular Biomarkers and Diagnostics, Merck Clinical Labs
  • Kenneth J. Bloom, M.D., Chief Medical Officer, Laboratory and Genomic Services, GE Healthcare
  • Khaled Ali, Ph.D., Senior Scientist, Amgen Oncology
  • Khursheed Anwer, Ph.D., MBA, Executive Vice President & CSO, Nucleic Acid Therapy, Celsion
  • Kim Dickinson, M.D., MBA, MPH, Medical Director, Lab Corp Clinical Trials; President, Digital Pathology Association
  • Kirk M. Ririe, CEO & Founder, BS, BioFire Defense
  • Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University, Medical Center Hamburg-Eppendorf, University of Hamburg
  • Kristen Cleveland, PMP, Senior IT Project Manager, R&D IT, Biogen Idec
  • Kristen M. Smith, Ph.D., Scientist II, Bionomics, Inc
  • Kristina Warton, Ph.D., Senior Research Officer, Cancer, University of New South Wales and Kinghorn Cancer Centre, Garvan Institute
  • Larsson Omberg, Ph.D., Principal Scientist and Head of Data Science, Sage Bionetworks
  • Laszlo Radvanyi, Ph.D., CSO, Lion Biotechnologies
  • Laura J. van ‘t Veer, Ph.D., Professor of Laboratory Medicine, University of California San Francisco; Leader, Breast Oncology Program; Associate Director, Applied Genomics, UCSF Helen Diller Family Comprehensive Cancer Center; Principal Investigator, Bay Area Breast Cancer SPORE; Angela and Shu Kai Chan Endowed Chair in Cancer Research
  • Leonora Balaj, Ph.D., Researcher, Massachusetts General Hospital, Harvard Medical School
  • Leslie Crews, Ph.D., Assistant Project Scientist, Catriona Jamieson Laboratory, Sanford Consortium for Regenerative Medicine and MooresUCSD Cancer Center
  • Liron Pantanowitz, M.D., Associate Professor, Pathology, University of Pittsburgh Medical Center
  • Lisa M. Coussens, Ph.D., Professor and Chair, Director, Basic Research, Department of Cell & Developmental Biology, Knight Cancer Institute, Oregon Health & Sciences University
  • Lon Castle, M.D., Medical Director, Managed Care, Medical Affairs, CardioDx
  • Loren Joseph, M.D., Medical Director, Molecular Diagnostics & Cancer Genetics, Pathology, Laboratory Medicine, Beth Israel Deaconess Medical Center and Harvard Medical School (2014 Chair, AMP Clinical Practice Committee.
  • Lucy A. Godley, M.D., Ph.D., Associate Professor, Medicine, Hematology/Oncology, Cancer Research Center, The University of Chicago
  • Luis A. Diaz, M.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
  • M.A. Nezami, M.D., President, Cancer Epigenetics, Pacific Medical Center of Hope
  • Macey Johnson III, Vice President, Managed Care and Reimbursement, bioTheranostics, Inc.
  • Magali Haas, M.D., Ph.D., Founder and CEO, Orion Bionetworks
  • Manolis Kellis, Ph.D., Professor, Computer Science, MIT; Director, Computational Biology Group, Computer Science and Artificial Intelligence Lab (CSAIL), Broad Institute of MIT and Harvard
  • Mara Aspinall, MBA, former CEO, Ventana Medical Systems
  • Marcel E. Dinger, Ph.D., Head, Clinical Genomics, Kinghorn Center for Clinical Informatics, Garvin Institute of Medical Research
  • Mark Boguski, M.D., Ph.D., Founder & CMO, Genome Health Solutions.
  • Mark Erlander, Ph.D., CSO, Trovagene, Inc.
  • Mark I. Evans, M.D., Professor, Obstetrics & Gynecology, Mount Sinai School of Medicine; Director, Comprehensive Genetics PLL
  • Mark J. Routbort, M.D., Ph.D., Director, Computational and Integrational Pathology; Associate Professor, Hematopathology; Medical Director, Laboratory Informatics, UT MD Anderson Cancer Center
  • Mark Monane, M.D., MS, Chief Medical Officer, CardioDx, Inc.
  • Mark Roskey, Ph.D., Vice President & General Manager, Applications & Reagents, Quanterix
  • Mark Schreiber, Ph.D., Director, Information Architecture, Merck Research Laboratories
  • Martin Gollery, CEO, Tahoe Informatics
  • Martin Leach, Ph.D., Vice President, R&D IT, Biogen Idec
  • Martin Siaw, Ph.D., Associate Scientific Director, Advanced Sequencing, Quest Diagnostics Nichols Institute
  • Mary Alikian, MSc, Clinical Scientist, Imperial Molecular Pathology, Imperial College
  • Matthew E. Roth, Ph.D., Assistant Professor & Co-Director, Bioinformatics Research Lab, Baylor College of Medicine
  • Matthew Porteus, M.D., Ph.D., Associate Professor, Pediatrics, Stanford University School of Medicine
  • Maya Kasowski, Ph.D., Fellow, Synder Lab, Genetics, Stanford University
  • Megan Hitchins, Ph.D., Associate Professor, Department of Medicine, Division of Oncology, Stanford School of Medicine
  • Melina Cimler, Ph.D., Vice President, Head, Global Quality, Illumina, Inc.
  • Metin N. Gurcan, Ph.D., Associate Professor, Biomedical Informatics, The Ohio State University
  • Michael Angelo, M.D., Ph.D., Instructor, Pathology, Stanford University
  • Michael Bassik, Ph.D., Assistant Professor, Department of Genetics, Stanford University
  • Michael C. Montalto, Ph.D., Senior Vice President, Clinical, Medical & Scientific Affairs, GE Healthcare
  • Michael D. Feldman, M.D., Ph.D., Associate Professor, Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania
  • Michael E. Klepser, Pharm.D., FCCP, Professor, Pharmacy Practice, Ferris State University College of Pharmacy
  • Michael H. Elliott, CEO, Atrium Research & Consulting LLC
  • Michael H.A. Roehrl, M.D., Ph.D., Director, UHN Program in BioSpecimen Sciences, University of Toronto
  • Michael J. Heller, Ph.D., Professor, Nanoengineering & Bioengineering, University of California San Diego
  • Michael Keiser, Ph.D., Assistant Professor, Institute for Neurodegenerative Diseases, University of California San Francisco, School of Medicine
  • Michael Liebman, Ph.D., Managing Director, IPQ Analytics, LLC
  • Michael Morse, M.D., MHS, FACP, Professor, Medicine, Medical Oncology, Duke University Medical Center
  • Michael W. Riben, M.D., Medical Director, Laboratory Informatics; Associate Professor, Pathology, MD Anderson Cancer Center
  • Michelle M. Hanna, Ph.D., CEO & Scientific Director, RiboMed
  • Mitch Raponi, Ph.D., Senior Director, Molecular Diagnostics, Clovis Oncology
  • Monica J. Basehore, Ph.D., FACMG, Lead Director, Molecular Diagnostic Laboratory; Associate Director, Medical Genetics Training Program, Greenwood Genetic Center
  • Monica Wang, Ph.D., Lead Software Engineer, Project and Program Manager, Research Systems, Takeda
  • Muller Fabbri, M.D, Ph.D., St. Baldrick’s Foundation Scholar; Assistant Professor, Pediatrics and Molecular Microbiology & Immunology, Norris Comprehensive Cancer Center, University of Southern California- Keck School of Medicine; Children’s Hospital Los Angeles
  • Muneesh Tewari, M.D., Ph.D., Associate Professor, University of Michigan
  • N. Reginald Beer, Ph.D., Medical Diagnostics Initiative Leader, Lawrence Livermore National Laboratory
  • Nada Jabado, M.D., Ph.D., Associate Professor, Pediatrics; Associate Member, Human Genetics, Oncology and Experimental Medicine, McGill University
  • Nazneen Aziz, Ph.D., Senior Vice President & Chief Research Officer, Phoenix Children’s Hospital
  • Neal Goodwin, Ph.D., Vice President, Corporate Research and Development, Champions Oncology
  • Nicholas C. Dracopoli, Ph.D., Vice President, Oncology Translational Research, Janssen R&D, Johnson & Johnson
  • Nicholas J. Schork, Ph.D., Professor and Director, Human Biology, J. Craig Venter Institute
  • Nicole Teed, MS, CGC, Senior Medical Science Liaison, Sequenom Laboratories
  • Nikolas H. Stoecklein, M.D., Professor, General Visceral and Pediatric Surgery, University Hospital of the Heinrich-Heine, University of Düsseldorf
  • Olivier P. Nolan-Stevaux, Ph.D., Senior Scientist, Department of Oncology, Amgen, Inc.
  • Pam Baker, Senior Director, Market Access, Sales Strategy & Ops, CardioDx, Inc.
  • Pamela B. Cassidy, Ph.D., Research Associate Professor, Dermatology, Oregon Health and Science University
  • Pamela L. Swatkowski, Director, Regulatory Affairs, Abbott Molecular, Inc.
  • Pankaj Agarwal, Ph.D., Director, Systematic Drug Repositioning, Computational Biology, GlaxoSmithKline
  • Pat Basu, M.D., CMO, Doctor on Demand
  • Patrick Loerch, Director, Health IT, Information Technology, Merck & Co.
  • Paul A. van de Wiel, Ph.D., Senior Director, Precision and Decentralized Diagnostics, Philips Research
  • Paul D. Grossman, Ph.D., Venture Partner, Telegraph Hill Partners.
  • Paul G. Rothberg, Ph.D., Professor, Pathology & Lab Medicine, University of Rochester Medical Center (AMP Clinical Practice Committee, Genetics Subdivision Representative)
  • Paul J. McCracken, Ph.D., Director, Imaging Biomarkers and Personalized Medicine, Eisai
  • Paul R. Billings, M.D., Ph.D., CMO (Consulting)
  • Paula M. Cannon Ph.D., Associate Professor, Molecular Microbiology & Immunology, Biochemistry, and Pediatrics, Keck School of Medicine, University of Southern California
  • Peter Byers, M.D., Director, Center for Precision Diagnostics; Professor, Pathology, Medicine & Genome Sciences, University of Washington School of Medicine
  • Peter Houghton, Ph.D., Director, Center for Childhood Cancer, The Research Institute, Nationwide Children’s Hospital
  • Peter P. Lee, City of Hope, Billy Wilder Endowed Professor, Chair, Cancer Immunotherapeutics & Tumor Immunology (CITI), City of Hope Comprehensive Cancer Center
  • Philip C. Mack, Ph.D., Associate Adjunct Professor, Internal Medicine, Hematology and Oncology, University of California Davis Medical Center
  • Philip L. Felgner, Ph.D., Director, Protein Microarray Laboratory, Infectious Disease; Project Scientist, Epidemiology, University of California, Irvine School of Medicine
  • Philip Martin, D.V.M., Veterinary Pathologist, Center for Advanced Preclinical Research (CAPR), Frederick National Laboratory for Cancer Research & Leidos Biomedical Research, Inc.
  • Qi Zhao, Ph.D., Assistant Investigator, Ludwig Collaborative Laboratory, Department of Neurosurgery, Johns Hopkins University
  • Rachael E. Hawtin, Ph.D., Vice President & Head, Research, Nodality
  • Raghu Kalluri, M.D., Ph.D., Professor & Chair, Cancer Biology, MD Anderson Cancer Center
  • Rajaram Krishnan, Ph.D., CEO, Bioengineering, Biological Dynamics, Inc.
  • Rajendra Joshi, Ph.D., Associate Director and Head, Bioinformatics Group, Centre for Development of Advanced Computing, Pune University Campu
  • Rakesh Dixit, Ph.D., DABT, Vice President, R&D; Global Head Biologics Safety Assessment, Pathology and LAR, MedImmune (AstraZeneca Biologics)
  • Rakesh Radhakrishnan, Principal (Chief) IS Security Architect, Amgen
  • Rashid Al Ali, Ph.D., Deputy Chief Research Officer and Division Chief Biomedical Informatics, Sidra Medical and Research Center
  • Ravi Madduri, Fellow, Computation Institute, University of Chicago and Argonne National Lab
  • Reinhold Pollner, Ph.D., Director, Clinical Trial Assay Development, Genoptix Medical Laboratory, a Novartis Company
  • Richard A. Morgan, Ph.D., Vice President, Immunotherapy, Bluebird Bio
  • Rina Wolf, Vice President, Commercialization Strategies, Consulting and Industry Affairs, XIFIN, Inc
  • Robert A. Bonomo, M.D., Chief, Medical Service, Louis Stokes Cleveland VA Hospital; Vice Chair, Veterans Affair, Medicine, University Hospital Case Medical Center
  • Robert C. Green, M.D., MPH, Director, G2P Research Program; Associate Director, Research, Partners Center for Personalized Genetic Medicine, Division of Genetics, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School
  • Robert Grossman, Ph.D., Chief Research Informatics Officer (CRIO); Director, Center in Data Intensive Science; Professor, Biological Sciences, University of Chicago; Core Faculty and Senior Fellow, Institute for Genomics and Systems Biology (IGSB) and the Computation Institute
  • Robert J. Boland, Senior Manager, External Innovation R&D IT, Janssen, Pharmaceutical Companies of Johnson & Johnson
  • Robert Lutz, Ph.D., Vice President, Translational Research and Development, ImmunoGe
  • Robert M. Kuhn, Ph.D., Associate Director, Genome Browser, Center for Biomolecular Science & Engineering, University of California Santa Cruz
  • Robert M. Umek, Meso-Scale Diagnostic
  • Robert Mashal, Ph.D., CEO, NKT Therapeutics
  • Robert Michel, Editor-In-Chief, The Dark Report
  • Robert Palais, Ph.D., Associate Professor, Math Dept, Utah Valley University; Research Professor, Pathology Dept, University of Utah
  • Robert Penny, M.D., Ph.D., CEO, Paradigm
  • Robert Pierce, M.D., CMO, OncoSec Medical, Inc.
  • Robin Harper Cowie, Director, Reimbursement, Biodesix, Inc..
  • Rodger Novak, M.D., CEO, CRISPR Therapeutics
  • Ronald W. Davis, Ph.D., Professor of Biochemistry and Genetics, Director, Stanford Genome Technology Center, Stanford University
  • Rong Mao, M.D., Associate Professor, Pathology, University of Utah; Medical Director, Molecular Genetics, ARUP Laboratorie
  • Ross L. Levine, M.D., Associate Member, HOPP; Associate Attending, Leukemia Service; Memorial Sloan-Kettering Cancer Center
  • Roy Baynes, M.D., Senior Vice President, Global Clinical Development, Merck
  • Ryan Kim, Ph.D., Director, UC Davis Genome Center, DNA Technologies and Expression Analysis Cores, University of California, Davis
  • Sabrina Li, CEO, Coyote Bioscience Company
  • Sabrina Molinaro, Ph.D., Head, Epidemiology, Institute of Clinical Physiology, National Research Council - CNR Italy
  • Sam LaBrie, Ph.D., Vice President,
  • Sameek Roychowdhury, M.D., Ph.D., Assistant Professor, Internal Medicine, Ohio State University Comprehensive Cancer Center
  • Sandra Gesing, Ph.D., Research Assistant Professor, Center for Research Computing, University of Notre Dame
  • Sandra M. Gaston, Ph.D., Director, Molecular Biomarkers Research Laboratory,Pathology and Laboratory Medicine, Tufts Medical Center Assistant Professor of Pathology, Tufts University School of Medicine
  • Santosh Putta, Ph.D., Vice President, Computational Sciences, Nodality, Inc.
  • Sarah Byron, Ph.D., Diagnostics Assessment Program, National Institute for Health and Care Excellence.
  • Saumya Pant, Ph.D., Research Fellow, Merck Research Laboratories, Molecular Biomarkers and Diagnostic
  • Scot W. Ebbinghaus, Executive Director, Clinical Research, Merck
  • Scott Kahn, Ph.D., Vice President, Commercial Enterprise Informatics, Illumina
  • Sebastien Lefebvre, Director, R&D IT Platform, Biogen Idec
  • Seth D. Crosby, M.D., Director, Partnerships, Genetics, Washington University
  • Shannon L. Stott, Ph.D., Assistant Professor, Medicine, Massachusetts General Hospital and Harvard Medical School
  • Shelly Gunn, M.D., Ph.D, CMO, MolecularHealth, Inc.
  • Sherie Smalley, M.D., Chief, Medical Policy & Benefits Branch, UPMC Health Pla.
  • Shidong Jia, Ph.D., Scientist, Genentech
  • Shinsaku Togo, M.D., Ph.D., Associate Professor, Division of Respiratory Medicine, Faculty of Medicine & Graduate School of Medicine, Juntendo University
  • Shirin Khambata Ford, Ph.D., Executive Director, US Hematology and Oncology Medical Affairs, Celgene Corporation
  • Shoibal Datta, Ph.D., Director, Data Sciences, Biogen Idec
  • Shuqi Chen, Ph.D., Vice President, Point-of-Care R&D, Roche Molecular System, Inc.
  • Simon Williams, Ph.D., Principal Scientist, Biomedical Imaging, Genentech
  • Sohrab Shah, Ph.D., Assistant Professor, Pathology and Computer Science, University of British Columbia; Scientist, BC Cancer Agency
  • Sorena Nadaf, Director, Translational and Biomedical Informatics; CIO, HDFCCC Translational Informatics, University of California San Francisco
  • Stan Rose, Ph.D., CEO, Transplant Genomics.
  • Stanley R. Frankel, M.D., Medical Sciences Executive Medical Director, Oncology Early Development, Therapeutic Area Head, Amgen
  • Stefanie Jeffrey, M.D., John and Marva Warnock Professor, Surgery; Chief of Surgical Oncology Research, Stanford University School of Medicine and Klaus Pantel, M.D., Professor and Founding Director, Institute of Tumor Biology, University, Medical Center Hamburg-Eppendorf, University of Hamburg
  • Steffan N. Ho, M.D., Ph.D., Senior Director, Early Development and Translational Oncology, Pfizer Oncology
  • Stephanie I. Fraley, Ph.D., Assistant Professor, Bioengineering, University of California San Diego Johns Hopkins
  • Steve Cashman, Founder & CEO, Health Spot
  • Steven A. Soper, Ph.D., William H. Pryor Emeritus Professor, Biomedical Engineering and Chemistry, University of North Carolina, Chapel Hill
  • Stuart S. Martin, Ph.D., Associate Professor, Physiology, Greenebaum Cancer Center, University of Maryland School of Medicine
  • Sunney Xie, Ph.D., Mallinckrodt Professor, Chemistry and Chemical Biology, Harvard University
  • Sury Vepa, Ph.D., J.D., Senior Licensing and Patenting Manager, Office of Intramural Research; Office of Technology Transfer, NIh
  • Susan Clark, Ph.D., Professor & Director, Epigenomics Centre, The Kinghorn Cancer Centre, Garvan Institute of Medical Research
  • Susie Stephens, Senior Director, Oncology & West Coast IT, Pfizer
  • Taiping Chen, Ph.D., Associate Professor, Department of Molecular Carcinogenesis, Division of Basic Science Research, The University of Texas MD Anderson Cancer Center
  • Timothy K. Lu, M.D., Ph.D., Associate Professor, Synthetic Biology Group, Department of Electrical Engineering and Computer Science and Department of Biological Engineering, Synthetic Biology Center
  • Timothy Moran, Director, Life Science Research, Product Marketing, BIOVIA
  • Timothy Swaller, Vice President, Genomics, Ceres, Inc.
  • Tobias D. Barker, M.D., Vice President, Medical Operations, MinuteClinic, CVS Caremark
  • Todd M. Lowe, Ph.D., CSO, Maverix Biomics, Inc.
  • Tuuli Lappalainen, Ph.D., Principal Investigator & Core Member, New York Genome Center; Assistant Professor, Systems Biology, Columbia University
  • Valerie Ng, M.D., Ph.D., Chair, Laboratory Medicine & Pathology, Alameda Heath System/Highland General Hospital
  • Valerie Taly, Ph.D., Group Leader, Translational Research and Microfluidics, University Paris Descartes.
  • Victor Velculescu, M.D., Ph.D., Associate Professor, Oncology, Johns Hopkins Sidney Kimmel Cancer Center
  • Victoria M. Pratt, Ph.D., FACMG, Director, Pharmacogenomics Laboratory, Medical and Molecular Genetics, Indiana University School of Medicine
  • W. Fraser Symmans, M.D., Professor & Director, Research Operations, Pathology, UT MD Anderson Cancer Center
  • Wang-Xia Wang, Ph.D., Senior Scientist, Sanders-Brown Center on Aging, University of Kentucky
  • William (Bill) Watt, Ph.D., University of Washington Tumor Vaccine Group; CEO & Co-Founder, EpiThany, Inc.
  • William James Greenleaf, Ph.D., Assistant Professor, Department of Genetics, Stanford University School of Medicine
  • Yan Yang, Director, Laboratory Operations, In Vivo Services, The Jackson Laboratory
  • Yijun Ruan, Ph.D., Professor and Director, Genome Sciences, Jackson Laboratory Genomic Medicine
  • Yukako Yagi, Ph.D., Director, MGH Pathology Imaging & Communication Technology (PICT) Center, Massachusetts General Hospital; Affiliated Faculty, Wellman Center for Photomedicine, Massachusetts General Hospital; Assistant Professor of Pathology, Harvard Medical School
  • Yuval Itan, Ph.D., M.Res., Postdoctoral Associate, Human Genetics of Infectious Diseases, The Rockefeller University
  • Z. Hugh Fan, Ph.D., Professor, Mechanical and Aerospace Engineering, University of Florida
  • Zhong Wang, Ph.D., Computational Biologist & Genome Analysis Group Lead, Lawrence Berkeley National Lab & DOE Joint Genome Institute; Adjunct Associate Professor, University of California at Merced



*as of September 26, 2014

Japan-Flag Korea-Flag China-Simplified-Flag China-Traditional-Flag 

 

2015 MMTC Final Agenda 

Premier Sponsors:

Abbott Molecular 

 

Elsevier 


Jackson Laboratory - small logo 

Leica Biosystems 
 

 NanoString2   

 

Silicon Biosystems 

 

Singulex 

Thomson Reuters-Large